Headlines

Dr. Maes Awarded R01 from the National Institute on Drug Abuse (NIDA)

Dr. Hermine Maes was awarded R01 (DA063061) from the National Institute on Drug Abuse (NIDA) on June 30, 2025. This project, conducted with collaborators Dr. Naomi P. Friedman (University of Colorado Boulder), Dr. Pamela A. Madden (Washington University in St. Louis), and Drs. Monica Luciana and Sylia Wilson (University of Minnesota), examines vulnerability to substance use in adolescents. By integrating nationwide longitudinal samples with twin family data, the study will examine how internalizing and externalizing ...

Continue reading →
0

Dr. Kaitlin Bountress and other MPIs awarded R34 through NIH/NIDA

Dr. Kaitlin Bountress, along with other MPIs Drs. Gretchen Neigh, Peter Hamilton, and Mathew Banks, were awarded a R34 through NIH/NIDA R34 (R34DA061267).
This project seeks to establish a multidisciplinary and functionally diverse team and generate preliminary data across-species (i.e., in rat, human data) in order to improve our understanding of behavioral biomarkers and genetic risk factors for neurocognitive behaviors related to substance use disorder risk. The ultimate goal of this line of work is to improve our ...

Continue reading →
0

VCU Researcher Awarded DOD Grant to Identify Genetic Risk Factors for Persistent Concussion Symptoms and PTSD

Dr. Christina Sheerin, along with other MPIs Dr. Amstadter and Dr. Disner (University of Minnesota) were awarded a 3-year Investigator Initiated grant through the Traumatic Brain Injury and Psychological Health Research Program of the Department of Defense (TP230074).

This project leverages a longitudinal registry study and biorepository of military service members and veterans and seeks to use novel genetic approaches to characterize the genetic architecture and functional consequences of genetic risk on persistent post concussive symptoms, PTSD, and AUD ...

Continue reading →
0